Published in Eur J Med Chem on December 17, 2011
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem Rev (2016) 1.02
Oxaliplatin analogues with carboxy derivatives of boldine with enhanced antioxidant activity. Bioinorg Chem Appl (2015) 0.75
Impact of a 2-year multimodal intervention for disruptive 6-year-olds on substance use in adolescence: randomised controlled trial. Br J Psychiatry (2013) 1.50
X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J Biol Chem (2009) 1.44
Larger amygdala but no change in hippocampal volume in 10-year-old children exposed to maternal depressive symptomatology since birth. Proc Natl Acad Sci U S A (2011) 1.44
Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Apoptosis (2008) 1.37
AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecol Oncol (2004) 1.22
Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation. J Biol Chem (2013) 1.22
Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol (2011) 1.18
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer (2006) 1.18
Invisible displacement understanding in domestic dogs (Canis familiaris): the role of visual cues in search behavior. Anim Cogn (2006) 1.18
Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer (2009) 1.14
Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. Mol Cancer (2004) 1.07
Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. Exp Cell Res (2012) 1.06
Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol (2004) 1.05
Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation. Mol Cell Biol (2011) 1.03
Pubertal development, personality, and substance use: a 10-year longitudinal study from childhood to adolescence. J Abnorm Psychol (2013) 1.01
Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1. Int J Oncol (2003) 0.98
Regulation of prohibitin expression during follicular development and atresia in the mammalian ovary. Biol Reprod (2004) 0.94
Daycare attendance, stress, and mental health. Can J Psychiatry (2006) 0.91
XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling. Mol Cancer (2010) 0.91
TGF-beta expression during rat pregnancy and activity on decidual cell survival. Reprod Biol Endocrinol (2005) 0.90
Regulation of Akt expression and phosphorylation by 17beta-estradiol in the rat uterus during estrous cycle. Reprod Biol Endocrinol (2003) 0.89
Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins. PLoS One (2012) 0.89
Different neurocognitive functions regulating physical aggression and hyperactivity in early childhood. J Child Psychol Psychiatry (2009) 0.87
Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells. Gynecol Oncol (2012) 0.87
Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17beta-estradiol at estrus. Reprod Biol Endocrinol (2003) 0.86
Thyroid toxicity due to subchronic exposure to a complex mixture of 16 organochlorines, lead, and cadmium. Toxicol Sci (2002) 0.86
Advances in the development of hybrid anticancer drugs. Expert Opin Drug Discov (2013) 0.86
Nuclear factor kappaB-mediated induction of Flice-like inhibitory protein prevents tumor necrosis factor alpha-induced apoptosis in rat granulosa cells. Biol Reprod (2002) 0.86
Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens. Int J Oncol (2007) 0.86
Serotonergic contribution to boys' behavioral regulation. PLoS One (2011) 0.85
Inhibitory effects of cytoskeleton disrupting drugs and GDP-locked Rab mutants on bradykinin B₂ receptor cycling. Pharmacol Res (2013) 0.85
Ubiquitin-proteasomal degradation of COX-2 in TGF-β stimulated human endometrial cells is mediated through endoplasmic reticulum mannosidase I. Endocrinology (2011) 0.85
Transforming growth factor Beta regulates proliferation and invasion of rat placental cell lines. Biol Reprod (2010) 0.83
A facile synthesis of C(2)-symmetric 17 beta-estradiol dimers. Bioorg Med Chem Lett (2003) 0.83
Expression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroids. Reprod Biol Endocrinol (2010) 0.82
Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells. Int J Cancer (2011) 0.82
Akt isoforms regulate intermediate filament protein levels in epithelial carcinoma cells. FEBS Lett (2010) 0.82
Leukemia inhibitory factor regulates differentiation of trophoblastlike BeWo cells through the activation of JAK/STAT and MAPK3/1 MAP kinase-signaling pathways. Biol Reprod (2012) 0.82
Relating kindergarten attention to subsequent developmental pathways of classroom engagement in elementary school. J Abnorm Child Psychol (2012) 0.81
Optimized N-phenyl-N'-(2-chloroethyl)ureas as potential antineoplastic agents: synthesis and growth inhibition activity. Bioorg Med Chem (2005) 0.81
Effects of inactivation-resistant agonists on the signalling, desensitization and down-regulation of bradykinin B(2) receptors. Br J Pharmacol (2009) 0.81
Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells. Mol Immunol (2011) 0.81
Transforming growth factor beta isoforms regulation of Akt activity and XIAP levels in rat endometrium during estrous cycle, in a model of pseudopregnancy and in cultured decidual cells. Reprod Biol Endocrinol (2009) 0.81
Oxytocin increases invasive properties of endometrial cancer cells through phosphatidylinositol 3-kinase/AKT-dependent up-regulation of cyclooxygenase-1, -2, and X-linked inhibitor of apoptosis protein. Biol Reprod (2011) 0.81
Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance. BMC Cancer (2013) 0.81
Synthesis of unique 17beta-estradiol homo-dimers, estrogen receptors binding affinity evaluation and cytocidal activity on breast, intestinal and skin cancer cell lines. Steroids (2006) 0.81
Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro. Reprod Biol Endocrinol (2007) 0.81
VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo. Endocr Relat Cancer (2009) 0.81
Resveratrol modulates the expression of PTGS2 and cellular proliferation in the normal rat endometrium in an AKT-dependent manner. Biol Reprod (2011) 0.80
Biological evaluation of novel estrogen-platinum(II) hybrid molecules on uterine and ovarian cancers-molecular modeling studies. Bioorg Med Chem Lett (2004) 0.80
Regulation of prostaglandin D synthase and prostacyclin synthase in the endometrium of cyclic, pregnant, and pseudopregnant rats and their regulation by sex steroids. J Endocrinol (2007) 0.79
Steroid-linked nitrogen mustards as potential anticancer therapeutics: a review. J Steroid Biochem Mol Biol (2013) 0.79
N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site. Bioorg Med Chem (2007) 0.79
First synthesis of separable isomeric testosterone dimers showing differential activities on prostate cancer cells. Bioorg Med Chem Lett (2010) 0.79
Synthesis of 17beta-estradiol platinum(II) complexes: biological evaluation on breast cancer cell lines. Bioorg Med Chem Lett (2003) 0.79
Transfer RNA bindings to antitumor estradiol-platinum(II) hybrid and cisplatin. DNA Cell Biol (2008) 0.79
Involvement of transforming growth factor alpha in the regulation of rat ovarian X-linked inhibitor of apoptosis protein expression and follicular growth by follicle-stimulating hormone. Biol Reprod (2002) 0.78